Table 1.
Variable | No of participants |
25-hydroxyvitamin D (ng/ml) Mean (95% CI) |
p-value | Albuminuria prevalence* percent (95% CI) |
p-value |
---|---|---|---|---|---|
| |||||
All participants | 8,789 | 25.0 (24.3–25.7) | 12.8 (11.7–13.9) | ||
| |||||
Age | |||||
6–11 years old | 2,683 | 26.6 (25.8–27.4) | 13.6 (11.9–15.3) | ||
12–19 years old | 6,106 | 23.9 (23.2–24.7) | 12.3 (11.0–13.6) | ||
<.0001 | <.0001 | ||||
| |||||
Sex | |||||
Female | 4,402 | 24.4 (23.7–25.1) | 17.7 (16.0–19.3) | ||
Male | 4,387 | 25.6 (24.8–26.3) | 8.2 (7.0–9.5) | ||
<.0001 | <.0001 | ||||
| |||||
Race/ethnicity | |||||
Non-Hispanic white | 2,386 | 28.0 (27.3–28.8) | 13.7 (12.0–15.4) | ||
Non-Hispanic black | 2,918 | 17.0 (16.3–17.8) | 10.5 (8.9–12.1) | ||
Hispanic | 3,098 | 22.3 (21.7–22.9) | 12.7 (10.9–14.5) | ||
Other | 387 | 22.3 (20.9–23.7) | 9.9 (6.3–13.4) | ||
<.0001 | 0.019 | ||||
| |||||
Body Mass Index | |||||
Normal | 5,556 | 26.0 (25.3–26.7) | 15.3 (13.9–16.7) | ||
Overweight | 1,437 | 24.4 (23.5–25.2) | 10.7 (8.5–13.0) | ||
Obese | 1,725 | 21.9 (21.2–22.6) | 5.5 (3.9–7.1) | ||
<.0001 | <.0001 | ||||
| |||||
Diabetes | |||||
No | 8,738 | 25.0 (24.3–25.7) | 12.8 (11.7–13.9) | ||
Yes | 51 | 22.9 (20.4–25.5) | 12.1 (0.9–23.2) | ||
0.099 | 0.901 | ||||
| |||||
Blood pressure | |||||
Normal | 7,148 | 24.7 (24.0–25.4) | 12.6 (11.4–13.8) | ||
Pre-Hypertension | 325 | 24.7 (23.0–26.4) | 13.2 (7.6–18.7) | ||
Hypertension | 205 | 22.3 (20.0–24.6) | 21.0 (12.4–29.7) | ||
0.098 | 0.037 |
Values are expressed as means or prevalence with 95% confidence interval (CI) in parentheses and are weighed to NHANES sampling distributions.
Albuminuria is defined as an albumin to creatinine ratio (ACR) ≥30 mg/g. To convert 25-hydroxyvitamin D in ng/mL to nmol/L, multiply by 2.496. BMI categories: normal is < 85th percentile, overweight is 85- 94th percentile, obese is ≥ 95th percentile. BP categories: normal is SBP and DBP <90th percentile, pre-Hypertension is SBP or DBP ≥ 90th percentile but <95th percentile, Hypertension is ≥ 95th percentile